Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from Weight Loss

The targeted programme found to improve IVF outcomes

Women who took part in a weight loss programme had a 21 per cent higher chance of becoming pregnant – whether naturally or through IVF

The Independent UK

Altimmune Q2 FY2025 Earnings Call Transcript

Altimmune, Inc. (NASDAQ:ALT) reported its second-quarter financial results before Tuesday’s opening bell.

Benzinga

Weight loss support before IVF could boost pregnancy chances – and reduce the need for treatment

Around one in five women of childbearing age are living with [obesity], defined by the World Health Organization as having a body mass index (BMI) over 30 kg/m². Compared with women in the healthy BMI range (18.5–24.9 kg/m²), those living with obesity are three times more likely to experience fertility…

The Conversation

From analysis to the latest developments in health,
read the most diverse news in one place.

The serious eye conditions linked to weight loss drugs

IN FULL

The Independent UK

Patient's heartbreaking final words before death

A woman uttered five striking words to her family from her hospital bed before she died of complications arising from her pursuit of a healthier life.

AAP

Trump GLP-1 Pilot Program Could Boost Novo Nordisk & Eli Lilly

Trump’s plan to cover weight loss drugs under Medicaid programs and Medicare Part D plans to could be a major tailwind for LLY and NVO, despite tarrif threats.

MarketBeat

Is Eli Lilly’s 14% Post-Earnings Slide a Buy-the-Dip Opportunity?

Weight loss drug goliath Eli Lilly just tanked despite posting impressive Q2 results. See what drove the decline and whether the market reaction is overdone.

MarketBeat

Read news from The Economist, FT, and more,
with one subscription

Portugal tightens rules on weight loss drug prescriptions to prevent misuse

Doctors from only four medical specialties will be able to write prescriptions for injectable drugs that are used to treat type 2 diabetes and obesity but are also popular for weight loss.

Euronews

Tammy Slaton defends decision to drink soda ‘in moderation’ amid weight loss journey

IN FULL

The Independent UK

Daily pill helps patients lose 12% of body weight in early trial

Results of study suggest orforglipron could be a simpler, cheaper alternative to injections

The Guardian - UK

Weight loss jabs and cancer risk: here’s what you need to know about the research so far

So many people in western countries are turning to weight loss drugs such as Wegovy/Ozempic and Mounjaro that concerns have started to emerge about maintaining ready supplies. But with popularity comes scrutiny, and rising demand isn’t the only potential problem with weight loss jabs.

The Conversation

'Ozempic Penis'? Male Users Claim Genital Growth After Weight Loss Jab Goes Viral

Men using Ozempic report genital growth after weight loss. Doctors say it's fat loss, not drug-related changes, sparking viral debate online.

International Business Times UK

This Blue-Chip Stock Is Cooking Up a Major Growth Catalyst

Eli Lilly is poised for a major boost as new data shows its diabetes drug Mounjaro offers heart health benefits, potentially making it the top choice for patients with Type 2 diabetes.

Barchart

Shares fall after weight loss pill disappoints in trial

IN FULL

The Independent UK

Get all your
news in one place.

100's of premium titles.
One news app.

Euronews

Eli Lilly will seek approval for experimental weight loss pill after promising study

Study participants lost an average of 12.4 per cent of their body weight over 72 weeks.

Benzinga

Eli Lilly's Rare Weight Loss Data Miss Could Benefit Competitors

On Thursday, Eli Lilly and Co.’s (NYSE:LLY) weight loss rival Novo Nordisk A/S (NYSE:NVO), along with smaller firms, Terns Pharmaceuticals, Inc. (NASDAQ:TERN), Viking Therapeutics Inc. (NASDAQ:VKTX), and Structure Therapeutics Inc. (NASDAQ:GPCR) are trading higher.

Evening Standard

High demand expected for new daily weight loss pill

The tablet could be a cheaper and more convenient alternative to injections.

The Independent UK

New weight loss pill more ‘tolerable’ than jabs shown to be effective in key trial

The tablet could be a cheaper and more convenient alternative to injections

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga

Eli Lilly's Closely Watched Obesity Pill Orforglipron Shows Around 12% Weight Loss But Trails Novo Nordisk (UPDATED)

Eli Lilly and Co. (NYSE:LLY) stock plunged on Thursday after the company released topline data from the Phase 3 ATTAIN-1 trial evaluating orforglipron, an investigational oral glucagon-like peptide-1 (GLP-1) receptor agonist.

The Independent UK

I’m a nutrition expert. Here’s what I wish everyone knew about weight loss

If you’re not seeing big changes on the scales, it may be more helpful to shift your focus

The Independent UK

1000-Lb. Sisters’ Tammy Slaton issues bizarre apology for drinking soda

The reality star revealed her dramatic weight loss during an April episode of her TLC show, ‘1000-lb. Sisters’

Evening Standard

EastEnders star reveals her secret to 6.5 stone weight loss: 'Best thing I've ever done'

The 49-year-old has undergone a dramatic transformation over the last two years

The Conversation

Five things I wish everyone knew about weight loss – by an expert in nutrition

Weight loss continues to dominate public discourse – often framed as a matter of personal responsibility. But after nearly 15 years working in and around health and nutrition research, I’ve seen how weight is treated differently from almost every other health issue.

The Independent UK

Frustration as people may miss out on weight loss jab because of where they live

IN FULL

The Independent UK

Ozempic could be hurting your gym gains — with potentially dangerous consequences

1 … 28 29 30 31

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

the World Health Organization

the University of Oxford

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.